Retinal transcriptome analysis in db/db mice after sodium-glucose cotransporter 2 inhibitor application

被引：0
|
作者：
Ahn, Jeeyun [1 ,2 ]
Shin, Jooyoung [1 ,2 ]
Park, Junghyun [3 ]
Moon, Min Kyong [4 ,5 ]
机构：
[1] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea
[2] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea
[3] Inje Univ, Seoul Paik Hosp, Dept Ophthalmol, Gimhae, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[5] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
5367
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effect of the sodium-glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
    Takahashi, Kiyohiko
    Nakamura, Akinobu
    Miyoshi, Hideaki
    Nomoto, Hiroshi
    Kitao, Naoyuki
    Omori, Kazuno
    Yamamoto, Kohei
    Cho, Kyu Yong
    Terauchi, Yasuo
    Atsumi, Tatsuya
    SCIENTIFIC REPORTS, 2018, 8
  • [2] Combination of a sodium-glucose cotransporter inhibitor and a PPAR gamma agonist on metabolic, parameters and body weight in female db/db mice
    Conway, B
    Chen, XL
    Osborne, M
    Demarest, K
    DIABETES, 2003, 52 : A115 - A115
  • [3] The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1
    Okamura, Takuro
    Hashimoto, Yoshitaka
    Osaka, Takafumi
    Fukuda, Takuya
    Hamaguchi, Masahide
    Fukui, Michiaki
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2019, 65 (01) : 23 - 28
  • [4] The Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Can Suppress Muscle Atrophy in Db/Db Mice by Suppressing the Expression of Foxo1
    Bamba, Ryo
    Kimura, Tomonori
    Okamura, Takuro
    Hashimoto, Yoshitaka
    Osaka, Takafumi
    Senmaru, Takafumi
    Fukui, Michiaki
    DIABETES, 2019, 68
  • [5] Pharmacokinetic and pharmacodynamic modeling for the effect of sodium-glucose cotransporter inhibitors on blood glucose level and renal glucose excretion in db/db mice
    Yamaguchi, Koji
    Kato, Motohiro
    Ozawa, Kazuharu
    Kawai, Takahiro
    Yata, Tatsuo
    Aso, Yoshinori
    Ishigai, Masaki
    Ikeda, Sachiya
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (11) : 4347 - 4356
  • [6] Differential effects of sodium-glucose cotransporter 2 inhibitor and low-carbohydrate diet on body composition and metabolic profile in obese diabetic db/db mice
    Kusakabe, Toru
    Yokota, Shigefumi
    Shimizu, Mika
    Inoue, Takayuki
    Tanaka, Masashi
    Ohue-Kitano, Ryuji
    Muranaka, Kazuya
    Yamakage, Hajime
    Wada, Hiromichi
    Hasegawa, Koji
    Satoh-Asahara, Noriko
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [7] Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages
    Kiyohiko Takahashi
    Akinobu Nakamura
    Hideaki Miyoshi
    Hiroshi Nomoto
    Naoyuki Kitao
    Kazuno Omori
    Kohei Yamamoto
    Kyu Yong Cho
    Yasuo Terauchi
    Tatsuya Atsumi
    Scientific Reports, 8
  • [8] The effects of empagliflozin, a novel sodium glucose cotransporter-2 inhibitor, on glucose homeostasis and pancreatic beta cell mass in db/db mice
    Mayoux, E.
    Klein, T.
    Grempler, R.
    Michael, M.
    Tahbaz, A.
    Naderali, E. K.
    DIABETIC MEDICINE, 2014, 31 : 66 - 66
  • [9] Long-Term Treatment with the Sodium Glucose Cotransporter 2 Inhibitor, Dapagliflozin, Ameliorates Glucose Homeostasis and Diabetic Nephropathy in db/db Mice
    Terami, Naoto
    Ogawa, Daisuke
    Tachibana, Hiromi
    Hatanaka, Takashi
    Wada, Jun
    Nakatsuka, Atsuko
    Eguchi, Jun
    Horiguchi, Chikage Sato
    Nishii, Naoko
    Yamada, Hiroshi
    Takei, Kohji
    Makino, Hirofumi
    PLOS ONE, 2014, 9 (06):
  • [10] Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice
    Nagata, T.
    Fukuzawa, T.
    Takeda, M.
    Fukazawa, M.
    Mori, T.
    Nihei, T.
    Honda, K.
    Suzuki, Y.
    Kawabe, Y.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 170 (03) : 519 - 531
12345